“The Nuffield report suggests that there is a moral imperative for investment into GM crop research in developing countries. But the moral imperative is in fact the opposite. The policy of drawing of funds away from low-cost sustainable agriculture research, towards hi-tech, exclusive, expensive and unsafe technology is itself ethically questionable. There is a strong moral argument that the funding of GM technology in agriculture is harming the long-term sustainability of agriculture in the developing world.” WorldLongCountryFactsStrongTermMoralTechnologyPolicyCostLowsResearchArgumentOppositesInvestmentDrawingDevelopingLong TermExpensiveReportsFundSustainabilityAgricultureExclusiveImperativesFundingCropsQuestionableUnsafeDeveloping CountriesSustainable Agriculture Author:Tewolde Berhan Gebre Egziabher
“Setting an aggressive enough carbon-reduction goal will result in an appropriate price for carbon and will help many a renewable technology. Consumer education will help. Most importantly, though, will be the continually declining cost trajectory of the real breakthrough in clean-technology costs driven by research and innovation. In the end, private capital is the real barometer of change.” RealEndsEnoughHelpingGoalResultsTechnologyCostResearchInnovationCleanDrivenSettingSettingsConsumersAppropriateAggressiveCarbonBreakthroughReductionTrajectoryBarometerResearch And Innovation Author:Vinod Khosla
“Pharmaceutical companies have invested hundreds of millions of dollars in new HIV/AIDS treatments not out of altruism but because they can make up those research costs in sales.” CompanyMillionsCostResearchDollarsAidsTreatmentAltruismHivPharmaceuticalHiv AidsPharmaceutical Companies Author:David Mixner
“Drug companies say they need to charge ever-higher prices to cover their research costs, but they spend far less on research and development than they do on marketing and administration, and afterwards they actually keep more in profits.” NeedsCompanyDevelopmentHigherCostDrugResearchMarketingProfitAdministrationResearch And DevelopmentDrug Companies Author:Marcia Angell
“While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.” ValuesNationsSupportFocusDevelopmentCostDrugResearchImportanceWealthySeniorPrescriptionsPharmaceuticalResearch And DevelopmentPrescription DrugsGreat Value Author:Michael K. Simpson